AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects

Update Il y a 4 ans
Reference: NCT00970775

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This is a Phase I, single centre, randomised, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability and pharmacokinetics of AZD2423 following single ascending dose administration to healthy Japanese subjects.


Inclusion criteria

  • healthy volunteer

Links